Clinical Trials

LACOG 0215 - EVA 001


Prospective evaluation of patients with uterine cervical cancer in Brazilian health institutions - The EVITA I study

Primary Objective

Characterization of uterine cervical cancer in the Brazilian population



All patients diagnosed with CC in 1-year period (IIB to IIA high risk or IIB-IVB or recurrent disease) at the participating sites will be included. Data will be collected in LACOG selected sites (N=14). 

Sample size: 800

Sponsor: Roche

Status: Recruiting.

Scientific comittee:  Angélica Nogueira-Rodrigues, Andréia Cristina de Melo, Aknar Freire de Carvalho Calabrich, Fernando Cotait Maluf, Gustavo Werustky

LACOG 0215 - EVA 001

Registry NCT02671071


Phone: 55 51 3384 5334